UP Matrix ScorecardLast updated: May 2026

Taimaka

Taimaka has dramatially reduced delivery costs for ORSZ, a well-established intervention. They have also received a significant GiveWell grant. If they can replicate their model at scale, without balooning costs, they will be very impactful and cost-effective.

Overall Rating
Cost Effectiveness Rating
Cost Effectiveness Rationale9-13xGiveWell Benchmark
Our RecommendationBuy

Key Information

Overview

Taimaka trainings community health workers to do door-to-door screening for malnutrition, to provide treatment at outpatient clinics, to procure ready-to-use therapeutic food and antibiotics, and to cover the costs of transporting children and their caregivers to health facilities.

RegistrationUS
Turnover (USD)$1.5m
StageLate mid-stage
Countries ActiveNigeria
54321Intervention Evidence QualityOrganisation Evidence QualityPotential for ScalePayer-at-scale InterestFit for Global Health Fund
The UP Index™3.4 / 5

Pathways to Scale

Payer-at-scale Interest
Government Adoption
Franchise/Replication (by other NGOs)
Commercial Revenue

Impact Metrics

Death prevented (per $1M at scale)233
ConfidenceMedium
Cost per DALY avertedN/A
Total annual reach20,000 children treated

International Evidence

Intervention Evidence QualityRationale: No RCTs for ethical reasons, but strong medical consensus
Medium
Quasi-Experimentalyes
Single RCTno
Multiple RCTsno
Meta-Analysisno

Implementation Evidence

Organisation / Programme Evidence QualityRationale: Successful pilot
Medium
Pilot Studyyes
Quasi-Experimentalno
Single RCTno
Multiple RCTsno
↓ Download PDF